18194711000001108: Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual medicinal product\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Tacrolimus\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\UK product\Virtual therapeutic moiety\Tacrolimus\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\UK product\Trade family\Protopic\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)

\Medicinal product\Product manufactured as cutaneous dose form\Product containing tacrolimus in cutaneous dose form (medicinal product form)\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing calcineurin inhibitor\Product containing tacrolimus\Tacrolimus\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing calcineurin inhibitor\Product containing tacrolimus\Tacrolimus\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing hydrolase inhibitor\Product containing calcineurin inhibitor\Product containing tacrolimus\Product containing tacrolimus in cutaneous dose form (medicinal product form)\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tacrolimus\Tacrolimus\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tacrolimus\Tacrolimus\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing tacrolimus\Product containing tacrolimus in cutaneous dose form (medicinal product form)\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Product containing tacrolimus\Tacrolimus\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Product containing tacrolimus\Tacrolimus\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing macrolide\Product containing tacrolimus\Product containing tacrolimus in cutaneous dose form (medicinal product form)\Product containing only tacrolimus in cutaneous dose form (medicinal product form)\Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment\Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

62434801000001111 Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

62434901000001117 Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel Import - supplier (qualifier value)	false	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Is a	Product containing precisely tacrolimus (as tacrolimus monohydrate) 1 milligram/1 gram conventional release cutaneous ointment	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has active ingredient	Tacrolimus	false	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has manufactured dose form	Cutaneous AND/OR transdermal dosage form	false	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Tacrolimus monohydrate	false	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has dispensed dose form	Ointment	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Tacrolimus	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Is a	Protopic	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has specific active ingredient	Tacrolimus monohydrate	true	Inferred relationship	Existential restriction modifier
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Has basis of strength substance	Tacrolimus	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) 30 gram	Has AMP	True	Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
62434801000001111	Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
62434901000001117	Protopic 0.1% ointment (Mawdsley-Brooks & Company Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module